Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Show:
Annual
Income Statement
All numbers in thousandsBreakdown
ttm
2020-12-31
2019-12-31
2018-12-31
Total Revenue
25,767,000
25,424,000
23,362,000
23,747,000
Cost of Revenue
6,333,000
6,159,000
4,356,000
4,101,000
Gross Profit
19,434,000
19,265,000
19,006,000
19,646,000
Operating Expenses
Research Development
4,700,000
4,207,000
4,116,000
3,737,000
Selling General and Administrative
5,716,000
5,730,000
5,150,000
5,332,000
Total Operating Expenses
10,586,000
10,126,000
9,332,000
9,383,000
Operating Income or Loss
8,848,000
9,139,000
9,674,000
10,263,000
Interest Expense
1,180,000
1,262,000
1,289,000
1,392,000
Income Before Tax
6,447,000
8,133,000
9,138,000
9,545,000
Income Tax Expense
838,000
869,000
1,296,000
1,151,000
Income from Continuing Operations
5,609,000
7,264,000
7,842,000
8,394,000
Net Income
5,609,000
7,264,000
7,842,000
8,394,000
Net Income available to common shareholders
5,609,000
7,264,000
7,842,000
8,394,000
Basic EPS
-
12.40
12.96
12.70
Diluted EPS
-
12.31
12.88
12.62
Basic Average Shares
-
586,000
605,000
661,000
Diluted Average Shares
-
590,000
609,000
665,000
EBITDA
-
12,996,000
12,633,000
12,883,000
